Takeda Pharmaceutical Company Limited Logo

Takeda Pharmaceutical Company Limited

A global, R&D-driven biopharmaceutical company discovering and delivering treatments.

4502 | T

Overview

Corporate Details

ISIN(s):
JP3463000004 (+1 more)
LEI:
Country:
Japan
Address:
大阪市中央区道修町四丁目1番1号

Description

Takeda Pharmaceutical Company Limited is a global, patient-focused, and R&D-driven biopharmaceutical company dedicated to discovering and delivering life-transforming treatments. The company's mission is to provide better health for people and a brighter future for the world. Its core therapeutic areas of focus include oncology, rare diseases, neuroscience, and gastroenterology. Takeda also invests significantly in Plasma-Derived Therapies and Vaccines. The company's operations encompass the entire pharmaceutical value chain, from translating science into highly innovative medicines through research and development to manufacturing, sales, and marketing on a global scale.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-04-14 04:57
発行登録書(株券、社債券等)
Japanese ZIP 37.1 KB
2025-03-13 03:57
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.9 KB
2025-02-13 03:51
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 27.1 KB
2025-01-30 08:02
臨時報告書
Japanese ZIP 24.5 KB
2024-12-18 05:02
訂正臨時報告書
Japanese ZIP 28.9 KB
2024-10-31 07:16
確認書
Japanese ZIP 9.4 KB
2024-10-31 07:14
半期報告書-第148期(2024/04/01-2025/03/31)
Japanese ZIP 502.7 KB
2024-09-26 08:06
臨時報告書
Japanese ZIP 22.9 KB
2024-07-02 04:53
臨時報告書
Japanese ZIP 31.5 KB
2024-06-26 09:02
内部統制報告書-第147期(2023/04/01-2024/03/31)
Japanese ZIP 26.9 KB
2024-06-26 09:02
確認書
Japanese ZIP 9.3 KB
2024-06-26 09:01
有価証券報告書-第147期(2023/04/01-2024/03/31)
Japanese ZIP 3.0 MB
2024-06-20 07:00
大量保有報告書
Japanese ZIP 40.5 KB
2024-02-02 05:00
四半期報告書-第147期第3四半期(2023/10/01-2023/12/31)
Japanese ZIP 532.5 KB
2024-02-02 05:00
確認書
Japanese ZIP 9.4 KB

Automate Your Workflow. Get a real-time feed of all Takeda Pharmaceutical Company Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Takeda Pharmaceutical Company Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Takeda Pharmaceutical Company Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.